Stock Scorecard
Stock Summary for Harmony Biosciences Holdings Inc (HRMY) - $35.65 as of 5/13/2025 12:59:02 PM EST
Total Score
18 out of 30
Safety Score
55 out of 100
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for HRMY
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for HRMY
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for HRMY
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for HRMY
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for HRMY (55 out of 100)
| Stock Price Rating (Max of 10) | 8 |
| Historical Stock Price Rating (Max of 10) | 8 |
| Stock Price Trend (Max of 10) | 2 |
| Book Value (Max of 10) | 5 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 6 |
| Trading Volume (Max of 10) | 8 |
| Price to Earnings (Max of 10) | 9 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for HRMY
Financial Details for HRMY
Company Overview |
|
|---|---|
| Ticker | HRMY |
| Company Name | Harmony Biosciences Holdings Inc |
| Country | USA |
| Description | Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and markets therapies for patients with rare neurological disorders. The company is headquartered in Plymouth Meeting, Pennsylvania. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 3/31/2025 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 35.65 |
| Price 4 Years Ago | 42.64 |
| Last Day Price Updated | 5/13/2025 12:59:02 PM EST |
| Last Day Volume | 958,561 |
| Average Daily Volume | 753,356 |
| 52-Week High | 41.61 |
| 52-Week Low | 26.47 |
| Last Price to 52 Week Low | 34.68% |
Valuation Measures |
|
| Trailing PE | 13.00 |
| Industry PE | 30.10 |
| Sector PE | 47.92 |
| 5-Year Average PE | 27.50 |
| Free Cash Flow Ratio | 4.18 |
| Industry Free Cash Flow Ratio | 18.49 |
| Sector Free Cash Flow Ratio | 30.82 |
| Current Ratio Most Recent Quarter | 3.67 |
| Total Cash Per Share | 8.52 |
| Book Value Per Share Most Recent Quarter | 12.55 |
| Price to Book Ratio | 2.67 |
| Industry Price to Book Ratio | 35.42 |
| Sector Price to Book Ratio | 27.83 |
| Price to Sales Ratio Twelve Trailing Months | 2.63 |
| Industry Price to Sales Ratio Twelve Trailing Months | 89.39 |
| Sector Price to Sales Ratio Twelve Trailing Months | 25.47 |
| Analyst Buy Ratings | 5 |
| Analyst Strong Buy Ratings | 3 |
Share Statistics |
|
| Total Shares Outstanding | 57,424,000 |
| Market Capitalization | 2,047,165,600 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 16.40% |
| Annual Earnings Growth | 12.91% |
| Reported EPS 12 Trailing Months | 2.62 |
| Reported EPS Past Year | 0.78 |
| Reported EPS Prior Year | 2.74 |
| Net Income Twelve Trailing Months | 152,719,000 |
| Net Income Past Year | 145,493,000 |
| Net Income Prior Year | 128,853,000 |
| Quarterly Revenue Growth YOY | 19.50% |
| 5-Year Revenue Growth | 160.18% |
| Operating Margin Twelve Trailing Months | 30.40% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 488,998,000 |
| Total Cash Past Year | 453,001,000 |
| Total Cash Prior Year | 311,660,000 |
| Net Cash Position Most Recent Quarter | 330,816,000 |
| Net Cash Position Past Year | 289,985,000 |
| Long Term Debt Past Year | 163,016,000 |
| Long Term Debt Prior Year | 178,566,000 |
| Total Debt Most Recent Quarter | 158,182,000 |
| Equity to Debt Ratio Past Year | 0.80 |
| Equity to Debt Ratio Most Recent Quarter | 0.82 |
| Total Stockholder Equity Past Year | 659,155,000 |
| Total Stockholder Equity Prior Year | 466,992,000 |
| Total Stockholder Equity Most Recent Quarter | 720,525,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 221,391,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 3.86 |
| Free Cash Flow Past Year | 218,668,000 |
| Free Cash Flow Prior Year | 219,075,000 |
Options |
|
| Put/Call Ratio | 0.13 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.54 |
| MACD Signal | -0.19 |
| 20-Day Bollinger Lower Band | 27.43 |
| 20-Day Bollinger Middle Band | 34.04 |
| 20-Day Bollinger Upper Band | 40.64 |
| Beta | 0.82 |
| RSI | 68.04 |
| 50-Day SMA | 33.99 |
| 150-Day SMA | 37.35 |
| 200-Day SMA | 37.94 |
System |
|
| Modified | 5/13/2025 1:57:08 AM EST |